Literature DB >> 1310826

Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization.

K Tanaka1, S Inoue, K Numata, Y Takamura, S Takebayashi, Y Ohaki, K Misugi.   

Abstract

Color Doppler sonographic findings on 38 lesions in 31 patients who had primary hepatocellular carcinoma were evaluated before and after transcatheter arterial embolization and compared with dynamic CT and hepatic arteriographic findings. All lesions that were observed with dynamic CT or arteriography were correctly identified on color Doppler sonography. Peritumoral pulsatile flow was the predominant color Doppler flow seen in all lesions. Mixed pulsatile and continuous flow were noted in larger tumors and in tumors with a higher degree of vascularity, as determined by arteriography. Two weeks after treatment, color Doppler flow was still identified in 18 lesions (47%), corresponding to dynamic CT or arteriographic findings documenting residual tumor. Histopathologic examination, performed in 10 other lesions, showed that the tumor was completely necrotic in five. These five necrotic tumors were not visible on color Doppler flow images after treatment. Viable tumor was observed in the five remaining lesions, all of which were shown on color Doppler flow images after treatment. During the 6- to 16-month follow-up period, color Doppler flow images showed recurrence of 13 (50%) of 26 lesions, corresponding to tumor recurrence as shown by CT and arteriography. We conclude that color Doppler sonography is useful for imaging hepatocellular carcinoma, for evaluating residual tumor after treatment, and for imaging tumor recurrence during follow-up.

Entities:  

Mesh:

Year:  1992        PMID: 1310826     DOI: 10.2214/ajr.158.3.1310826

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.

Authors:  Toshihide Shima; Masayuki Mizuno; Hideaki Otsuji; Chiemi Mizuno; Hirozumi Obata; Hyohun Park; Shinobu Nakajo; Takeshi Okanoue
Journal:  J Med Ultrason (2001)       Date:  2005-09       Impact factor: 1.314

2.  Clinical utility of doppler ultrasonography in evaluation of early therapeutic efficacy after transcatheter arterial embolization in patients with hepatocellular carcinoma.

Authors:  Toshio Hibi; Takashi Kumada; Kenji Takeshima; Masuhiro Ito; Takahiro Noda; Shigemasa Goto; Fumiyoshi Sugita; Toshi Sassa; Hideo Ichikawa; Satoshi Nakano
Journal:  J Med Ultrason (2001)       Date:  2002-06       Impact factor: 1.314

3.  Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging.

Authors:  Hyo Jin Kang; Jeong Min Lee; Sun Kyung Jeon; Hwaseong Ryu; Jeongin Yoo; Jae Keun Lee; Joon Koo Han
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

4.  The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.

Authors:  Youn Zoo Cho; So Yeon Park; Eun Hee Choi; Soon Koo Baik; Sang Ok Kwon; Young Ju Kim; Seung Hwan Cha; Moon Young Kim
Journal:  Clin Mol Hepatol       Date:  2015-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.